Remove 2014 Remove Imaging Modalities Remove Magnetic Resonance Imaging
article thumbnail

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

Imaging Technology

Dr. David Gauden, a co-founder of Blue Earth Diagnostics and with the company since 2014, assumes the role of full-time CEO of Bracco subsidiary Blue Earth Therapeutics. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Bracco Imaging S.p.A., Bracco Imaging S.p.A., Board of Directors.

article thumbnail

Emergency Guide to Stroke Neuroimaging

Northwestern EM

3] To identify a causative vascular lesion, which may or may not be amenable or contraindicatory to thrombolysis Non-Contrast Head CT NCCT is usually the first imaging modality obtained in the acute evaluation for stroke. A 2014 pooled analysis of 21 studies from 1993 to 2013 showed CTA has a sensitivity of 83.2%